Effects of empagliflozin on serum uric acid level of patients with type 2 diabetes mellitus: a systematic review and meta‐analysis

Figures

• 

  Fig. 1. The process of entering the studies into the systematic review and meta-analysis

• 

  Fig. 2. Forest plot showing the effect of empagliflozin on serum uric acid level

• 

  Fig. 3. Standard mean difference and 95% confidence intervals for changes in serum uric acid level for empagliflozin compared to compare group

• 

  Fig. 4. Subgroup Analysis of Randomized Controlled Trials and Observational Studies

• 

  Fig. 5. Forest plot showing the effect of empagliflozin on HBA1c level

• 

  Fig. 6. Standard mean difference and 95% confidence intervals for changes in serum HBA1c level for empagliflozin compared to compare group

• 

  Fig. 7. Forest plot showing the effect of empagliflozin on serum eGFR level

• 

  Fig. 8. Standard mean difference and 95% confidence intervals for changes in serum eGFR level for empagliflozin compared to compare group

• 

  Fig. 9. Forest plot showing the effect of empagliflozin on serum creatinine level

• 

  Fig. 10. Standard mean difference and 95% confidence intervals for changes in serum creatinine level for empagliflozin compared to compare group

• 

  Fig. 11. Forest plot showing the effect of empagliflozin on serum LDL level

• 

  Fig. 12. Standard mean difference and 95% confidence intervals for changes in serum LDL level for empagliflozin compared to compare group